by Sue Robbins | May 14, 2014 | Headache Drugs
An observational study was recently done by several fellows of the American Headache Society Headache Fellows Research Consortium. While it is generally believed that patient education and patient knowledge regarding triptan use for acute migraine management are...
by Sue Robbins | Oct 22, 2013 | Headache Drugs
Recently, a voluntary recall of PRAN brand turmeric spice powder was issued because it was found to contain high levels of lead. Turmeric is the main spice in curry. It also has a long history of use in herbal remedies, especially in China, India and Indonesia....
by Sue Robbins | Jun 20, 2013 | Headache Drugs
Dr. Robbins was recently interviewed for an article in the Daily Muse. The following is a portion of the article. Even if you got stuck with migraines in the genetic jackpot, you might not know this: June is National Migraine Awareness Month. And so today, I’m...
by Sue Robbins | May 20, 2013 | Headache Drugs
The U.S. Food and Drug Administration has approved the first generic versions of Zomig and Zomig-ZMT (orally disintegrating tablets). Zomig is in the class of drugs called triptans, and is indicated for the acute treatment of migraine with or without aura in adults....
by Sue Robbins | Apr 10, 2013 | Headache Drugs
Medication-overuse headache (MOH) happens when chronic headache patients see a worsening of their headaches, and react by using more acute medication, including NSAIDs and triptans. This in turn can exacerbate the headaches rather than ease the pain. MOH is defined by...
